Next Article in Journal
The Clinical Significance of Myosteatosis in Survival Outcomes in Patients with Hepatocellular Carcinoma Treated with Sorafenib
Next Article in Special Issue
Sargramostim for Prophylactic Management of Gastrointestinal Immune-Related Adverse Events of Immune Checkpoint Inhibitor Therapy for Cancer
Previous Article in Journal
Complete Primary Pathological Response Following Neoadjuvant Treatment and Radical Resection for Pancreatic Ductal Adenocarcinoma
Previous Article in Special Issue
Key Determinants of Immune-Mediated Adverse Reactions to Oncology Drugs
 
 
Article

Article Versions Notes

Cancers 2024, 16(2), 453; https://doi.org/10.3390/cancers16020453
Action Date Notes Link
article xml file uploaded 20 January 2024 13:48 CET Original file -
article xml uploaded. 20 January 2024 13:48 CET Update https://www.mdpi.com/2072-6694/16/2/453/xml
article pdf uploaded. 20 January 2024 13:48 CET Version of Record https://www.mdpi.com/2072-6694/16/2/453/pdf
article supplementary file uploaded. 20 January 2024 13:48 CET - https://www.mdpi.com/2072-6694/16/2/453#supplementary
article html file updated 20 January 2024 13:50 CET Original file https://www.mdpi.com/2072-6694/16/2/453/html
Back to TopTop